Myers Martin G, Kaczorowski Janusz, Dolovich Lisa, Tu Karen, Paterson J Michael
From the Schulich Heart Program, Sunnybrook Health Sciences Centre (M.G.M.), Institute for Clinical Evaluative Sciences (K.T., J.M.P.), University Health Network-Toronto Western Hospital Family Health Team (K.T.), Department of Medicine (M.G.M.), Department of Family and Community Medicine (K.T.), and Institute of Health Policy, Management and Evaluation (K.T., J.M.P.), University of Toronto, Toronto, Canada; the Department of Family and Emergency Medicine, Université de Montréal, and CRCHUM, Montreal, Canada (J.K.); the Department of Family Medicine, McMaster University, Hamilton, Canada (J.K., L.D., J.M.P.).
Hypertension. 2016 Oct;68(4):866-72. doi: 10.1161/HYPERTENSIONAHA.116.07721. Epub 2016 Aug 15.
The SPRINT (Systolic Blood Pressure Intervention Trial) reported that some older, higher risk patients might benefit from a target systolic blood pressure (BP) of <120 versus <140 mm Hg. However, it is not yet known how the BP target and measurement methods used in SPRINT relate to cardiovascular outcomes in real-world practice. SPRINT used the automated office BP technique, which requires the patient to be resting quietly and alone, with multiple readings being recorded automatically using an electronic oscillometric sphygmomanometer. We studied the relationship between achieved automated office BP at baseline and cardiovascular events in 6183 community-dwelling residents of Ontario aged ≥66 years who were receiving antihypertensive therapy and followed for a mean of 4.6 years. Adjusted hazard ratios (95% confidence intervals) were computed for 10 mm Hg increments in achieved automated office BP at baseline using Cox proportional hazards regression and the BP category with the lowest event rate as the reference category. Based on 904 fatal and nonfatal cardiovascular events, the nadir of cardiovascular events was at the systolic pressure category of 110 to 119 mm Hg, which was lower than the next highest category of 120 to 129 mm Hg (hazard ratio 1.30 [1.01, 1.66]). The hazard ratio for diastolic pressure was relatively unchanged above 60 mm Hg. Pulse pressure exhibited an increase in hazard ratio (1.33 [1.02, 1.72]) at ≥80 mm Hg. These results using automated office BP measurement in a usual treatment setting extend the finding in SPRINT of an optimum target systolic BP of <120 mm Hg to routine clinical practice.
收缩压干预试验(SPRINT)报告称,一些年龄较大、风险较高的患者,将收缩压目标设定为低于120毫米汞柱而非低于140毫米汞柱可能会受益。然而,尚不清楚SPRINT中使用的血压目标和测量方法在实际临床中与心血管结局有何关联。SPRINT采用了自动诊室血压测量技术,该技术要求患者独自安静休息,使用电子示波血压计自动记录多次读数。我们研究了安大略省6183名年龄≥66岁接受降压治疗的社区居民在基线时所测得的自动诊室血压与心血管事件之间的关系,这些居民平均随访了4.6年。使用Cox比例风险回归,以事件发生率最低的血压类别作为参照类别,计算基线时自动诊室血压每增加10毫米汞柱的校正风险比(95%置信区间)。基于904例致命和非致命心血管事件,心血管事件最低点出现在收缩压110至(含)119毫米汞柱类别,低于次高的120至(含)129毫米汞柱类别(风险比1.30 [1.01, 1.66])。舒张压高于60毫米汞柱时,风险比相对不变。脉压在≥80毫米汞柱时风险比升高(1.33 [1.02, 1.72])。在常规治疗环境中使用自动诊室血压测量的这些结果,将SPRINT中收缩压最佳目标<120毫米汞柱的研究结果扩展到了常规临床实践。